Preview

Experimental and Clinical Gastroenterology

Advanced search

Probable gastrointestinal disease factors in postmenopausal age women receiving antihypertensive therapy

https://doi.org/10.31146/1682-8658-ecg-217-9-99-106

Abstract

The frequency of achieving control as a result of taking antihypertensive drugs in women in the age group 55-64 years reaches 78.9%, the frequency of gastrointestinal symptoms occurring during treatment of hypertension is up to 62%. The aim: to analyze the probable causes of the development of symptoms of diseases of the gastrointestinal tract in postmenopausal patients receiving antihypertensive therapy. Material and methods. A comprehensive clinical examination of out-patient and in-patient patients of health care institutions of the Smolensk region with hypertension aged 50 to 84 years, (group AG, n=160) mean age 67.4 ± 17.4 years. Results. Complex examination and observation on the basis of standard methods with high probability shows the formation of gastroesophageal reflux disease, gastritis, simple erosions of the gastric mucosa, biliary dysfunction, chronic pancreatitis steatohepatosis in the observed patients. Conclusions: In postmenopausal women receiving antihypertensive therapy, there are major gastrointestinal symptoms of varying severity, arising in conditions of irrational nutrition, psycho-emotional and physical stress on the background of irregular medication. Based on the analysis of modern scientific sources, it can be argued that complex rational antihypertensive, antiplatelet, hypolipidemic, antisecretory and eradication therapy and the correction of modifiable risk factors ensures the achievement of remission of gastrointestinal and cardiovascular disease in the optimal time, improves the quality, life expectancy of patients and improves disease prognosis.

About the Authors

N. A. Konyshko
Federal State Autonomous Educational Institution of Higher Education I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Russian Federation


G. S. Konyshko
Smolensk State Medical University
Russian Federation


References

1. Lazebnik L.B., Tkachenko E. I., Abdulkhakov R. A. et al. [Standards for diagnosis and treatment of acid and Helicobacter pylori-associated diseases]. Eksp Klin Gastroenterol. 2013;(5):3-11.Russian. PMID: 24501939.@@ Лазебник Л. Б., Ткаченко Е. И., Абдулхаков Р. А., Бордин Д. С., Гриневич В. Б., Ливзан М. А., Минушкин О. Н., Осипенко М. Ф., Пасечников В. Д., Радченко В. Г., Рустамов М. Н., Сайфутдинов Р. Г., Самсонов А. А., Сарсенбаева А. С., Ситкин С. И., Симаненков В. Б., Старостин Б. Д., Яковенко Э. П. Стандарты диагностики и лечения кислотозависимых и ассоциированных с Helicobacter pylori заболеваний Экспериментальная и клиническая гастроэнтерология. -2013. -№ 5. - С. 3-11.

2. Lazebnik L.B., Radchenko V. G., Golovanova E. V.e tal. [Nonalcoholic fatty liver disease: diagnostic, symptoms, treatment. Guidelines were approved by the xv gastroenterological scientific society of russia in 2015]. Eksp Klin Gastroenterol. 2015;(7):85-96.Russian. PMID: 26817127.@@ Лазебник Л. Б., Радченко В. Г., Голованова Е. В., и др. Неалкогольная жировая болезнь печени: клиника, диагностика, лечение. Рекомендации утверждены XV съездом НОГР в 2015 году. Экспериментальная и клиническая гастроэнтерология. -2015. - № 7 (119). - С. 85-96.

3. Sogabe M., Okahisa T., Kimura T., Okamoto K., Miyamoto H., Muguruma N., Takayama T. Influence of metabolic syndrome on upper gastrointestinal disease. Clin J Gastroenterol. 2016 Aug;9(4):191-202. doi: 10.1007/s12328-016-0668-1.

4. Camilleri M., Malhi H., Acosta A. Gastrointestinal Complications of Obesity. Gastroenterology. 2017 May;152(7):1656-1670. doi: 10.1053/j.gastro.2016.12.052.

5. Kishida K., Funahashi T., Shimomura I. Adiponectin as a routine clinical biomarker. Best Pract Res Clin Endocrinol Metab. 2014 Jan;28(1):119-30. doi: 10.1016/j.beem.2013.08.006.

6. Sharma V., Aggarwal A. Helicobacter pylori: Does it add to risk of coronary artery disease. World J Cardiol. 2015 Jan 26;7(1):19-25. doi: 10.4330/wjc.v7.i1.19.

7. Sanghi S., MacLaughlin E.J., Jewell C. W., Chaffer S., Naus P. J., Watson L. E., Dostal D. E. Cyclooxygenase-2 inhibitors: a painful lesson. Cardiovasc Hematol Disord Drug Targets. 2006 Jun;6(2):85-100. doi: 10.2174/187152906777441803.

8. Palaniappan M., Selvarajan S., George M., Subramaniyan G., Dkhar S. A., Pillai A. A., Jayaraman B., Chandrasekaran A. Pattern of Adverse Drug Reactions Reported with Cardiovascular Drugs in a Tertiary Care Teaching Hospital. J Clin Diagn Res. 2015 Nov;9(11): FC01-4. doi: 10.7860/JCDR/2015/13810.6704.

9. Ivashkin V., Sheptulin A., Shifrin O., Poluektova E., Pavlov C., Ivashkin K., Drozdova A., Lyashenko O., Korolev A. Clinical validation of the “7 × 7” questionnaire for patients with functional gastrointestinal disorders. J Gastroenterol Hepatol. 2019 Jun;34(6):1042-1048. doi: 10.1111/jgh.14546.

10. National recommendations of the Russian Scientific Medical Society of Therapists for quantitative assessment of adherence to treatment. Materials of the XII National Congress of Therapists. Moscow. 2017. 24. (in Russ.)@@ Национальные рекомендации Российского научного медицинского общества терапевтов по количественной оценке приверженности к лечению. Материалы XII Национального Конгресса терапевтов. 2017.С.24.

11. [National recommendations for the diagnosis and treatment of arterial hypertension]. Moscow. (in Russ.)@@ Национальные рекомендации по диагностике и лечению артериальной гипертензии.


Review

For citations:


Konyshko N.A., Konyshko G.S. Probable gastrointestinal disease factors in postmenopausal age women receiving antihypertensive therapy. Experimental and Clinical Gastroenterology. 2023;(9):99-106. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-217-9-99-106

Views: 156


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1682-8658 (Print)